Valuation: Kyowa Kirin Co., Ltd.

Capitalization 1,34300Cr 844.13Cr 719.12Cr 665.51Cr 626.63Cr 1.17TCr 79TCr 1.19TCr 7.81TCr 3.05TCr 38TCr 3.17TCr 3.1TCr P/E ratio 2026 *
16.2x
P/E ratio 2027 * 16.4x
Enterprise value 1,10100Cr 692.12Cr 589.62Cr 545.67Cr 513.79Cr 957.01Cr 64TCr 976.62Cr 6.4TCr 2.5TCr 31TCr 2.6TCr 2.54TCr EV / Sales 2026 *
2.11x
EV / Sales 2027 * 2x
Free-Float
41.96%
Yield 2026 *
2.63%
Yield 2027 * 2.71%
1 day-2.10%
1 week-1.33%
Current month-0.47%
1 month+11.71%
3 months-0.19%
6 months+10.65%
Current year+1.54%
1 week 2,565.5
Extreme 2565.5
2,710
1 month 2,292
Extreme 2292
2,714.5
Current year 2,109
Extreme 2109
2,912
1 year 2,091.5
Extreme 2091.5
2,912
3 years 2,025
Extreme 2025
3,350
5 years 2,025
Extreme 2025
4,240
10 years 1,412
Extreme 1412
4,240
Manager TitleAgeSince
Chief Executive Officer - 01/03/2026
Director of Finance/CFO - 01/04/1986
Chief Tech/Sci/R&D Officer 59 01/03/2020
Director TitleAgeSince
Chairman 66 01/03/2025
Director/Board Member 70 01/03/2021
Director/Board Member 70 01/03/2022
Change 5d. change 1-year change 3-years change Capi.($)
-2.10%-1.33%+23.07%-13.25% 844.13Cr
+0.40%+1.87%-2.99%-35.46% 5.71TCr
+1.10%+5.16%+12.62%+84.59% 803.49Cr
+0.92%+4.68%-3.53%+42.34% 520.25Cr
-0.96%+0.11%-15.31%+72.34% 465.71Cr
-1.59%+0.40%+60.03%+37.61% 291.82Cr
+0.32%+0.16%-13.00%-37.70% 272.67Cr
+0.74%+4.31%+30.00%+35.83% 246.32Cr
+0.39%-1.33%+2.97%-15.72% 204.28Cr
+0.33%+1.43%+80.93%-1.77% 197.54Cr
Average -0.04%+1.47%+17.48%+16.88% 955.46Cr
Weighted average by Cap. +0.14%+1.77%+4.35%-8.79%

Financials

2026 *2027 *
Net sales 52TCr 327.28Cr 278.81Cr 258.02Cr 242.95Cr 452.53Cr 30TCr 461.8Cr 3.03TCr 1.18TCr 15TCr 1.23TCr 1.2TCr 53TCr 335.67Cr 285.96Cr 264.64Cr 249.18Cr 464.14Cr 31TCr 473.65Cr 3.1TCr 1.21TCr 15TCr 1.26TCr 1.23TCr
Net income 8.31TCr 52Cr 45Cr 41Cr 39Cr 72Cr 4.86TCr 74Cr 483.22Cr 189.07Cr 2.33TCr 196.06Cr 191.91Cr 8.19TCr 51Cr 44Cr 41Cr 38Cr 71Cr 4.79TCr 73Cr 476.15Cr 186.31Cr 2.3TCr 193.19Cr 189.1Cr
Net Debt -24TCr -152.01Cr -129.5Cr -119.85Cr -112.85Cr -210.19Cr -14TCr -214.5Cr -1.41TCr -550.13Cr -6.79TCr -570.47Cr -558.37Cr -27TCr -171.9Cr -146.44Cr -135.53Cr -127.61Cr -237.69Cr -16TCr -242.56Cr -1.59TCr -622.11Cr -7.68TCr -645.11Cr -631.43Cr
Logo Kyowa Kirin Co., Ltd.
Kyowa Kirin Co Ltd is a Japan-based company engaged in the manufacture and sale of medical drugs. The Company operates in Pharmaceuticals business segment. The Company engages in the research, development, manufacture, sale, and import & export of prescription pharmaceuticals. The Company has drug discovery technologies in antibody therapeutics and hematopoietic stem cell gene therapy. Its development pipeline includes AMG531 for aplastic anemia untreated with immunosuppressive therapy, KHK4083/AMG 451 for moderate to severe atopic dermatitis, KHK4083/AMG 451 for moderate to severe asthma, and KK2845 for acute myeloid leukemia and others. In addition, through its subsidiaries, the Company develops, manufactures, markets, and contracts out biosimilar pharmaceuticals, and engages in wholesale and retail sales and insurance agency business. The Company operates in Japan and overseas.
Employees
5,161
Date Price Change Volume
10/26/10 2,566.00 ¥ -2.10% 14,78,900
09/26/09 2,621.00 ¥ -0.36% 14,93,100
08/26/08 2,630.50 ¥ -1.16% 15,48,400
07/26/07 2,661.50 ¥ +0.57% 10,04,300
06/26/06 2,646.50 ¥ +1.77% 9,42,200
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
11
Last Close Price
2,566.00JPY
Average target price
2,140.91JPY
Spread / Average Target
-16.57%

Quarterly revenue - Rate of surprise